These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28986550)

  • 21. High-dose megestrol acetate in advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.
    Lentz SS; Brady MF; Major FJ; Reid GC; Soper JT
    J Clin Oncol; 1996 Feb; 14(2):357-61. PubMed ID: 8636744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hormonal therapy and chemotherapy of endometrial cancer].
    Krauss T; Huschmand H; Hinney B; Viereck V; Emons G
    Zentralbl Gynakol; 2002 Jan; 124(1):45-50. PubMed ID: 11873314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Curative effects of hysteroscopic resection combined with progesterone on early-stage endometrial cancer and its prognosis.
    Kuang J; Sun S; Xu H; Ni R; Ke F
    J BUON; 2021; 26(4):1320-1326. PubMed ID: 34564987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What is the clinical value of adding tamoxifen to progestins in the treatment [correction for treament] of advanced or recurrent endometrial cancer?
    Herzog TJ
    Gynecol Oncol; 2004 Jan; 92(1):1-3. PubMed ID: 14751129
    [No Abstract]   [Full Text] [Related]  

  • 25. Combination effects of paclitaxel with signaling inhibitors in endometrial cancer cells.
    Xu C; Li X; Li T; Wang X; Yang Y; Xiao L; Shen H
    Asian Pac J Cancer Prev; 2011; 12(11):2951-7. PubMed ID: 22393970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imatinib sensitizes endometrial cancer cells to cisplatin by targeting CD117-positive growth-competent cells.
    Zhang X; Kyo S; Nakamura M; Mizumoto Y; Maida Y; Bono Y; Takakura M; Fujiwara H
    Cancer Lett; 2014 Apr; 345(1):106-14. PubMed ID: 24333732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of adjunctive metformin to progesterone for the treatment of non-atypical endometrial hyperplasia in a randomized fashion, a placebo-controlled, double blind clinical trial.
    Tehranian A; Ghahghaei-Nezamabadi A; Arab M; Khalagi K; Aghajani R; Sadeghi S
    J Gynecol Obstet Hum Reprod; 2021 Jun; 50(6):101863. PubMed ID: 32652300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A potential synergistic anticancer effect of paclitaxel and amifostine on endometrial cancer.
    Dai D; Holmes AM; Nguyen T; Davies S; Theele DP; Verschraegen C; Leslie KK
    Cancer Res; 2005 Oct; 65(20):9517-24. PubMed ID: 16230417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Megestrol and tamoxifen in patients with advanced endometrial cancer: an Eastern Cooperative Oncology Group Study (E4882).
    Pandya KJ; Yeap BY; Weiner LM; Krook JE; Erban JK; Schinella RA; Davis TE
    Am J Clin Oncol; 2001 Feb; 24(1):43-6. PubMed ID: 11232948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pterostilbene Inhibits Human Multiple Myeloma Cells via ERK1/2 and JNK Pathway In Vitro and In Vivo.
    Xie B; Xu Z; Hu L; Chen G; Wei R; Yang G; Li B; Chang G; Sun X; Wu H; Zhang Y; Dai B; Tao Y; Shi J; Zhu W
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polyphyllin I Overcomes EMT-Associated Resistance to Erlotinib in Lung Cancer Cells via IL-6/STAT3 Pathway Inhibition.
    Lou W; Chen Y; Zhu KY; Deng H; Wu T; Wang J
    Biol Pharm Bull; 2017 Aug; 40(8):1306-1313. PubMed ID: 28515374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combinatorial therapy using dovitinib and ICI182.780 (fulvestrant) blocks tumoral activity of endometrial cancer cells.
    Eritja N; Domingo M; Dosil MA; Mirantes C; Santacana M; Valls J; Llombart-Cussac A; Matias-Guiu X; Dolcet X
    Mol Cancer Ther; 2014 Apr; 13(4):776-87. PubMed ID: 24448819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pterostilbene induces apoptosis and cell cycle arrest in diffuse large B-cell lymphoma cells.
    Kong Y; Chen G; Xu Z; Yang G; Li B; Wu X; Xiao W; Xie B; Hu L; Sun X; Chang G; Gao M; Gao L; Dai B; Tao Y; Zhu W; Shi J
    Sci Rep; 2016 Nov; 6():37417. PubMed ID: 27869173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pterostilbene inhibited tumor invasion via suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells.
    Pan MH; Chiou YS; Chen WJ; Wang JM; Badmaev V; Ho CT
    Carcinogenesis; 2009 Jul; 30(7):1234-42. PubMed ID: 19447859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. (E)-4-(3-(3,5-dimethoxyphenyl)allyl)-2-methoxyphenol inhibits growth of colon tumors in mice.
    Zheng J; Park MH; Son DJ; Choi MG; Choi JS; Nam KT; Kim HD; Rodriguez K; Gann B; Ham YW; Han SB; Hong JT
    Oncotarget; 2015 Dec; 6(39):41929-43. PubMed ID: 26474284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Megestrol acetate induced hypoadrenalism with cushingoid phenotype in endometrial cancer.
    Ozguroglu M; Yildiz O; Turna H; Kadioğlu P
    Gynecol Oncol; 2006 Apr; 101(1):183. PubMed ID: 16414105
    [No Abstract]   [Full Text] [Related]  

  • 37. Aromatase inhibitor letrozole in synergy with curcumin in the inhibition of xenografted endometrial carcinoma growth.
    Liang YJ; Hao Q; Wu YZ; Wang QL; Wang JD; Hu YL
    Int J Gynecol Cancer; 2009 Oct; 19(7):1248-52. PubMed ID: 19823063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting the Janus-activated kinase-2-STAT3 signalling pathway in pancreatic cancer using the HSP90 inhibitor ganetespib.
    Nagaraju GP; Mezina A; Shaib WL; Landry J; El-Rayes BF
    Eur J Cancer; 2016 Jan; 52():109-19. PubMed ID: 26682870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Megestrol acetate: first-line therapy for advanced breast cancer.
    Johnson PA; Bonomi PD; Anderson KM; Wolter JM; Economou SG
    Semin Oncol; 1986 Dec; 13(4 Suppl 4):15-9. PubMed ID: 3798124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of megestrol acetate (megace) in the treatment of patients with early endometrial adenocarcinoma: our experiences with 21 patients.
    Eftekhar Z; Izadi-Mood N; Yarandi F; Shojaei H; Rezaei Z; Mohagheghi S
    Int J Gynecol Cancer; 2009 Feb; 19(2):249-52. PubMed ID: 19396003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.